Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

NCT02547649 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

690

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: V114-A
BIOLOGICAL: V114-B
BIOLOGICAL: Prevnar 13®

Sponsor

Merck Sharp & Dohme LLC